FDA recall, , Moderate risk
Uvlizer Handheld Ultraviolet-C Germicidal Wands
A handheld ultraviolet-C germicidal wand can expose nearby persons to UVC radiation above safety limits.
Summary by Recall Canary from the FDA notice
What happened
Uvlizer c/o RAIS INTERNATIONAL LLC of Lewes, Delaware, recalled its handheld ultraviolet-C germicidal wand on March 6, 2026, because in some foreseeable use conditions the products can expose nearby persons to UVC radiation at levels significantly above limits recommended by international safety guidelines for skin and eye exposure. The wand contains a combination of five UV-A and UV-C LED lights, with two peak emission wavelengths at 274 nm and 397 nm.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Compare the details below with your product and check the FDA notice to confirm whether it is affected.
Product details
The product is a handheld ultraviolet-C germicidal wand and contains a combination of five UV-A and UV-C LED lights. The product comes in two configurations: UV-C x 1;
UV-A x 4, or UV-C x 2;
UV-A x 3. The product has two peak emission wavelengths at 274 nm and 397 nm.
Recall details
- Company began the recall
- Sold in
U.S.
- Company
- Uvlizer c/o RAIS INTERNATIONAL LLCLewes, Delaware
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98742
- Recall number
- Z-1808-2026
All recalls from Uvlizer c/o RAIS INTERNATIONAL LLC
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
